Friday, 16 October 2026European Markets

CORTICEIRA AMORIM And TESSENDERLO Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(VIANEWS) - CORTICEIRA AMORIM (COR.LS) is among this list of stock assets with the highest dividend rate and return on equity on the Basic Materials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
CORTICEIRA AMORIM (COR.LS) €10.10 4.04% 15.37%
TESSENDERLO (TESB.BR) €28.50 2.62% 8.87%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. CORTICEIRA AMORIM (COR.LS)

4.04% Forward Dividend Yield and 15.37% Return On Equity

Corticeira Amorim, S.G.P.S., S.A. manufactures and sells cork and cork related products worldwide. The company operates through Raw Materials, Cork Stoppers, Floor and Wall Coverings, Composite Cork, and Insulation Cork segments. It offers raw materials for cork and agroforestry markets; and cork stoppers for sparkling wine, spirit, beer, and cider industries. The company also provides cork composite solutions to use in various applications, such as aerospace, mobility, energy, sealing, construction, sports surfaces, flooring, home, office and leisure goods, footwear, panels, and composites. In addition, it offers insulation cork materials to use in sustainable construction/insulation, and interior and exterior designing. The company was founded in 1870 and is headquartered in Mozelos, Portugal. Corticeira Amorim, S.G.P.S., S.A operates as a subsidiary of Amorim Investimentos e Participações, S.G.P.S., S.A.

Earnings Per Share

As for profitability, CORTICEIRA AMORIM has a trailing twelve months EPS of €0.77.

PE Ratio

CORTICEIRA AMORIM has a trailing twelve months price to earnings ratio of 13.12. Meaning, the purchaser of the share is investing €13.12 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.37%.

Volatility

CORTICEIRA AMORIM's last week, last month's, and last quarter's current intraday variation average was a positive 0.57%, a negative 0.16%, and a positive 0.81%.

CORTICEIRA AMORIM's highest amplitude of average volatility was 0.97% (last week), 1.08% (last month), and 0.81% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

CORTICEIRA AMORIM's EBITDA is 29.11.

Volume

Today's last reported volume for CORTICEIRA AMORIM is 19138 which is 53.61% below its average volume of 41261.

More news about CORTICEIRA AMORIM.

2. TESSENDERLO (TESB.BR)

2.62% Forward Dividend Yield and 8.87% Return On Equity

Tessenderlo Group NV, together with its subsidiaries, engages in the agriculture, valorizing bio-residuals, energy, and industrial solution businesses worldwide. It operates through four segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power. The Agro segment engages in the production, marketing, and trading of crop nutrients, including liquid crop and potassium sulfate fertilizers, as well as crop protection products. This segment offers its specialty fertilizers under the Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, and SoluPotasse brands. The Bio-Valorization segment produces, sells, and trades in gelatins and collagen peptides, and proteins and fats for food, pharma, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions segment is involved in the production, sale, and trading of plastic pipe systems; water treatment chemicals; and other industrial activities, such as the production and sale of mining and industrial auxiliaries. The T-Power segment produces electricity through a combined cycle gas turbine of 425 MW capacity. It serves agriculture, food, industry, construction, health, and consumer goods end markets. The company was founded in 1919 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, TESSENDERLO has a trailing twelve months EPS of €2.73.

PE Ratio

TESSENDERLO has a trailing twelve months price to earnings ratio of 10.44. Meaning, the purchaser of the share is investing €10.44 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.87%.

Moving Average

TESSENDERLO's worth is under its 50-day moving average of €30.17 and under its 200-day moving average of €30.96.

Volume

Today's last reported volume for TESSENDERLO is 8107 which is 52.67% below its average volume of 17132.

More news about TESSENDERLO.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com